MetLife Investment Management’s Lumexa Imaging Holdings LMRI Stock Holding History

MetLife Investment Management’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$124K	Buy	+14,441	New	+$198K	﹤0.01%	2439

Other funds holding LMRI

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MetLife Investment Management's LMRI Position: Q1 2026 in Review

MetLife Investment Management opened a new position in Lumexa Imaging Holdings (LMRI) in Q1 2026: 14,441 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2439 among its holdings.

90 funds tracked by Wall St. Rank hold LMRI as of Q1 2026.

MetLife Investment Management held 14,441 shares of Lumexa Imaging Holdings worth $124K as of Q1 2026.
Lumexa Imaging Holdings was a new MetLife Investment Management position in Q1 2026.
Lumexa Imaging Holdings made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2439 holding.
90 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.